Scholarlink

<p><i>Bacillus velezensis</i> TCG15 is a bacterial isolate from soil that shows antifungal activity against <i>Aspergillus</i> spp. and <i>Candida spp</i>. This study aimed to characterize its antifungal activity. TCG15 produces cyclic lipopeptides (cLPs), including surfactin A, plipastatin, and bacillomycin L. We obtained the complete sequence of the operon encoding nonribosomal peptide synthetase for bacillomycin L biosynthesis, <i>bmyL</i> operon (<i>bmyLDABC</i>), using genome analysis of TCG15. The <i>bmyLD</i> gene-disrupted mutant did not produce bacillomycin L, plipastatin, or surfactin A. The mutant showed no antifungal activity, indicating an essential role of cLPs. Among the cLPs, bacillomycin L was identified as the key antifungal compound. This activity was enhanced by surfactin A, which showed no antifungal activity alone. These findings suggested that the synergistic interaction between bacillomycin L and surfactin A contributed to the antifungal activity of TCG15.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Characterization of the antifungal activity of the bacterial isolate Bacillus velezensis TCG15

  • 期刊论文

  • 发表日期：

    2025年5月30日

查看全文
  • Kojiro Ito,
  • Shun Tomita,
  • Takahiro Fujimaki,
  • Minenosuke Matsutani,
  • Gen Enomoto,
  • Akinobu Kajikawa,
  • Kei Asai,
  • Kenji Yokota

摘要

Bacillus velezensis TCG15 is a bacterial isolate from soil that shows antifungal activity against Aspergillus spp. and Candida spp. This study aimed to characterize its antifungal activity. TCG15 produces cyclic lipopeptides (cLPs), including surfactin A, plipastatin, and bacillomycin L. We obtained the complete sequence of the operon encoding nonribosomal peptide synthetase for bacillomycin L biosynthesis, bmyL operon (bmyLDABC), using genome analysis of TCG15. The bmyLD gene-disrupted mutant did not produce bacillomycin L, plipastatin, or surfactin A. The mutant showed no antifungal activity, indicating an essential role of cLPs. Among the cLPs, bacillomycin L was identified as the key antifungal compound. This activity was enhanced by surfactin A, which showed no antifungal activity alone. These findings suggested that the synergistic interaction between bacillomycin L and surfactin A contributed to the antifungal activity of TCG15.